Product image of Lecicarbon Za Odrasle (Sodium Hydrogen Carbonate, Sodium Dihydrogen Phosphate) supplied by GNH India

Lecicarbon Za Odrasle

Active Ingredient:
Sodium Hydrogen Carbonate, Sodium Dihydrogen Phosphate
Origin:
EU

Lecicarbon Za Odrasle (Sodium Hydrogen Carbonate, Sodium Dihydrogen Phosphate)

Sodium Hydrogen Carbonate, the active ingredient in Lecicarbon Za Odrasle, is an unknown drug class presented as an unknown strength/unknown form for rectal use. Its therapeutic purpose has not been publicly disclosed. Lecicarbon Za Odrasle also contains Sodium Dihydrogen Phosphate, which contributes to its rectal formulation.

GNH India supplies Lecicarbon Za Odrasle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Athenstaedt Gmbh & Co Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lecicarbon Za Odrasle is formulated for rectal administration and is associated with the following clinical applications:

  • Bowel preparation: Facilitates cleansing of the colon prior to endoscopic or surgical procedures.
  • Rectal pH adjustment: Helps normalize rectal acidity in certain therapeutic protocols.
  • Electrolyte supplementation: Provides local sodium and phosphate ions to support mucosal health.

How It Works

  • The combination of sodium hydrogen carbonate and sodium dihydrogen phosphate acts as a buffering system that modulates the local pH within the rectal lumen. By supplying bicarbonate and phosphate ions, the formulation creates an osmotic gradient that promotes fluid movement and assists in cleansing while maintaining electrolyte balance at the mucosal surface.

Side Effects

Lecicarbon Za Odrasle may be associated with the following adverse reactions.

Common Side Effects

  • Rectal irritation: mild burning or discomfort at the site of administration.
  • Abdominal cramping: transient spasms following rectal instillation.
  • Bloating or flatulence: excess gas due to osmotic activity.
  • Nausea: occasional feeling of queasiness.
  • Diarrhea: loose stools after use.
  • Mild electrolyte shift: slight changes in local sodium or phosphate levels.

Serious or Rare Side Effects

  • Severe electrolyte imbalance: significant alteration of systemic sodium or phosphate.
  • Profound abdominal pain: persistent or worsening pain requiring medical attention.
  • Allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Rectal bleeding: unexpected hemorrhage at the administration site.
  • Severe dehydration: excessive fluid loss leading to hypotension.
  • Metabolic alkalosis: systemic rise in pH due to bicarbonate absorption.

Precautions & Warnings

When considering Lecicarbon Za Odrasle, the following precautions are recommended.

  • Assess electrolyte status: evaluate serum sodium and phosphate before use.
  • Monitor for rectal irritation: discontinue if severe discomfort occurs.
  • Avoid in severe renal impairment: risk of accumulation of sodium and phosphate.
  • Pregnancy and breastfeeding: use only if clearly indicated after risk assessment.
  • Review concomitant laxatives: potential additive fluid loss.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Potential drug interactions with Lecicarbon Za Odrasle should be considered.

Major Interactions (Avoid)

  • Concurrent strong laxatives: may cause excessive fluid and electrolyte loss.
  • Intravenous sodium bicarbonate: risk of systemic alkalosis.

Moderate Interactions (Monitor Closely)

  • Oral phosphate binders: may reduce local phosphate availability.
  • Antacids containing bicarbonate: additive effect on pH balance.
  • Diuretics: may exacerbate electrolyte shifts.
  • Oral rehydration solutions: overlapping electrolyte content.
  • NSAIDs: potential for increased gastrointestinal irritation.

Frequently Asked Questions

Lecicarbon Za Odrasle is a rectally administered formulation that contains sodium hydrogen carbonate and sodium dihydrogen phosphate. It is primarily used to aid bowel cleansing before diagnostic or surgical procedures, to adjust local rectal pH, and to provide supplemental electrolytes to support mucosal health.

Sodium hydrogen carbonate acts as a buffering agent that raises the pH of the rectal environment. By neutralizing acidity, it creates an osmotic gradient that draws water into the lumen, facilitating cleansing while maintaining a balanced electrolyte environment.

The specific dose of Lecicarbon Za Odrasle is determined by the prescribing healthcare professional based on the patient’s condition, age, and clinical setting. The prescriber will select the appropriate volume and frequency for rectal administration.

Safety data for Lecicarbon Za Odrasle in pregnancy or lactation are limited. It should only be used when clearly needed and after a risk‑benefit assessment by the treating physician. Consultation with a obstetric specialist is advised.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike some polyethylene glycol‑based preparations, Lecicarbon Za Odrasle uses a bicarbonate‑phosphate buffer to cleanse the colon while also supplying electrolytes. This may result in a milder taste and different osmotic profile, but clinical choice depends on patient tolerance, procedural requirements and physician preference.

Store at ambient temperature: keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly sealed to maintain stability.

The product is administered rectally, typically as an enema. The prescribed volume is introduced into the rectum using a suitable applicator, and the patient is advised to retain the solution for a short period as directed by the healthcare provider.

Serious risks include severe electrolyte imbalance, metabolic alkalosis, significant abdominal pain, rectal bleeding, and rare allergic reactions such as anaphylaxis. Patients should be monitored for these signs, especially if they have underlying renal or cardiac conditions.

Patients with severe renal impairment, known hypersensitivity to sodium bicarbonate or phosphate salts, uncontrolled electrolyte disorders, or active rectal disease (e.g., severe ulcerative colitis) should avoid using this product unless a physician determines it is absolutely necessary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Hydrogen Carbonate, Sodium Dihydrogen Phosphate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT